期刊
TRENDS IN MOLECULAR MEDICINE
卷 21, 期 2, 页码 98-108出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2014.12.006
关键词
-
资金
- University Grants Committee Areas of Excellence Scheme of the Hong Kong SAR Government [AoE/M-04/06]
- Sequenom, Inc.
The discovery of cell-free fetal DNA in maternal plasma opened up new possibilities for noninvasive prenatal testing (NIPT). Conceptual advances in single-molecule counting have resulted in robust methods for the NIPT of fetal chromosomal aneuploidies and subchromosomal aberrations. Such methods are employed worldwide and are among the most rapidly adopted genomic tests. Furthermore, approaches for fetal whole-genome sequencing from maternal plasma, as well as for targeted detection of many single-gene disorders, have been reported. Recently, fetal methylome and transcriptome sequencing from maternal plasma have also been achieved, potentially allowing fetal physiological and pathological processes to be monitored noninvasively using maternal blood. These advances herald exciting future applications in prenatal medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据